Tissue Plasminogen Activator and MRI Signs of Cerebral Small Vessel Disease

Tissue Plasminogen Activator and MRI Signs of Cerebral Small Vessel Disease

Cerebral small vessel disease (SVD) is one of the leading causes of cognitive impairment and stroke. The importance of endothelial dysfunction and high blood−brain barrier (BBB) permeability in pathogenesis, together with ischemia, is under discussion. The aim of this study was to clarify...

Full description

Bibliographic Details
Main Authors:	Larisa A. Dobrynina, Alla A. Shabalina, Maryam R. Zabitova, Elena I. Kremneva, Zukhra Sh. Gadzhieva, Marina V. Krotenkova, Elena V. Gnedovskaya, Alexander B. Berdalin, Lyudmila A. Kalashnikova
Format:	Article
Language:	English
Published:	MDPI AG 2019-10-01
Series:	Brain Sciences
Subjects:	cerebral small vessel disease white matter hyperintensities perivascular spaces endothelial dysfunction tissue plasminogen activator blood–brain barrier
Online Access:	https://www.mdpi.com/2076-3425/9/10/266

Similar Items

Tissue-type plasminogen activator and MRI features of cerebral small vessel disease
by: Maryam R. Zabitova, et al.
Published: (2018-12-01)

MRI in the assessment of cerebral small vessel disease
by: Elena V. Gnedovskaya, et al.
Published: (2018-03-01)

MRI Types of Cerebral Small Vessel Disease and Circulating Markers of Vascular Wall Damage
by: Larisa A. Dobrynina, et al.
Published: (2020-05-01)

Plasminogen mediates communication between the peripheral and central immune systems during systemic immune challenge with lipopolysaccharide
by: Sarah K. Baker, et al.
Published: (2019-08-01)

L-Arginine-eNOS-NO Functional System in Brain Damage and Cognitive Impairments in Cerebral Small Vessel Disease
by: Larisa A. Dobrynina, et al.
Published: (2023-09-01)

Daily profile of arterial pressure and brain microstructural changes in patients with hypertension-related cerebral small vessel disease
by: Larisa A. Dobrynina, et al.
Published: (2019-03-01)

Neuropsychological profile and vascular risk factors in patients with cerebral microangiopathy
by: Larisa A. Dobrynina, et al.
Published: (2018-12-01)

Microstructural Predictors of Cognitive Impairment in Cerebral Small Vessel Disease and the Conditions of Their Formation
by: Larisa A. Dobrynina, et al.
Published: (2020-09-01)

Genetic considerations in cerebral small vessel diseases
by: Riwaj Bhagat, et al.
Published: (2023-04-01)

The role of arterial and venous blood flow and cerebrospinal fluid flow disturbances in the development of cognitive impairments in cerebral microangiopathy
by: Larisa A. Dobrynina, et al.
Published: (2019-06-01)

Glymphatic clearance function in patients with cerebral small vessel disease
by: Wenhua Zhang, et al.
Published: (2021-09-01)

Biomarkers involved in the pathogenesis of cerebral small-vessel disease
by: Xiaolu Liu, et al.
Published: (2022-09-01)

Changes in the MRI brain picture associated with newly diagnosed asymptomatic arterial hypertension
by: L. A. Dobrynina, et al.
Published: (2017-02-01)

Caliber of Intracranial Arteries as a Marker for Cerebral Small Vessel Disease
by: Zhaoyao Chen, et al.
Published: (2020-09-01)

Associations of deep medullary veins with vascular risk factors, laboratory indicators, and cerebral small vessel disease: A population‐based study
by: Yu Tian, et al.
Published: (2023-05-01)

Features of plasminogen activator inhibitor-1 synthesis by local fat depots of different localization in cardiovascular diseases
by: E. V. Belik, et al.
Published: (2022-05-01)

The assessment of cerebral white matter microstructure in cerebral small vessel disease based on the diffusion-weighted magnetic resonance imaging
by: Elena I. Kremneva, et al.
Published: (2020-03-01)

Association of Cerebral Small Vessel Disease Burden and Health-Related Quality of Life after Acute Ischemic Stroke
by: Yan Liang, et al.
Published: (2017-11-01)

The Effect of Cerebral Small Vessel Disease on the Subtypes of Mild Cognitive Impairment
by: Xudong Li, et al.
Published: (2021-07-01)

Plasminogen Receptors and Fibrinolysis
by: Lindsey A. Miles, et al.
Published: (2021-02-01)

Hyperintense vessels on imaging account for neurological function independent of lesion volume in acute ischemic stroke
by: Lisa D. Bunker, et al.
Published: (2022-01-01)

Compromised Blood–Brain Barrier Integrity Is Associated With Total Magnetic Resonance Imaging Burden of Cerebral Small Vessel Disease
by: Yue Li, et al.
Published: (2018-04-01)

Characterization of plasmin, plasminogen and plasminogen activator in goat milk
by: F. Polidori, et al.
Published: (2011-03-01)

Relations of impaired blood flow and cerebrospinal fluid flow with damage of strategic for cognitive impairment brain regiones in cerebral small vessel disease
by: Larisa A. Dobrynina, et al.
Published: (2022-06-01)

Subclinical Magnetic Resonance Imaging Markers of Cerebral Small Vessel Disease in Relation to Office and Ambulatory Blood Pressure Measurements
by: Jesus D. Melgarejo, et al.
Published: (2022-07-01)

Study of the sites of plasminogen molecule which are responsible for inhibitory effect of Lys-plasminogen on platelet aggregation
by: Y. M. Roka-Moya, et al.
Published: (2014-10-01)

Plasminogen interaction with Trypanosoma cruzi
by: Laura Almeida, et al.
Published: (2004-02-01)

Imaging features of small vessel disease in cerebral amyloid angiopathy among patients with Alzheimer’s disease
by: Nandakumar Nagaraja, et al.
Published: (2023-01-01)

Increased level of FAM19A5 is associated with cerebral small vessel disease and leads to a better outcome
by: Zhongnan Hao, et al.
Published: (2022-03-01)

Hemostasis System and Plasminogen Activity in Retrochorial Hematoma in the First Trimester of Pregnancy
by: Natalia B. Tikhonova, et al.
Published: (2022-09-01)

Survival, cognitive functions, and brain MRI in patients with cSVD: 5-year observation
by: Larisa A. Dobrynina, et al.
Published: (2022-12-01)

ISOLATION AND PURIFICATION OF A KRINGLE 5 FROM HUMAN PLASMINOGEN USING AH-SEPHAROSE
by: Kapustianenko L. G., et al.
Published: (2014-08-01)

PRODUCTION AND CHARACTERISTICS OF ANTIBODIES AGAINST K1-3 FRAGMENT OF HUMAN PLASMINOGEN
by: A. A. Tykhomyrov, et al.
Published: (2013-02-01)

White Matter Hyperintensities in Young Patients from a Neurological Outpatient Clinic: Prevalence, Risk Factors, and Correlation with Enlarged Perivascular Spaces
by: Qiaoqiao Zou, et al.
Published: (2023-03-01)

Fibrinolysis regulation by platelets retaining plasminogen and tissue-type plasminogen activator on their surface
by: T. Grinenko, et al.
Published: (2019-12-01)

Subclinical cerebral manifestations and changes of brain associated with newly diagnosed asymptomatic arterial hypertension
by: L. A. Dobrynina, et al.
Published: (2017-02-01)

Daily blood pressure profile and blood–brain barrier permeability in patients with cerebral small vessel disease
by: L. A. Dobrynina, et al.
Published: (2022-05-01)

The effect of anti-human plasminogen monoclonal antibodies on Glu-plasminogen activation by plasminogen activators
by: M. Akrami, et al.
Published: (2006-07-01)

Cerebral perivascular spaces as an important diagnostic marker of cerebral small vessel disease and brain pathology
by: S. P. Moskovko, et al.
Published: (2020-05-01)

Cerebral Vessels: An Overview of Anatomy, Physiology, and Role in the Drainage of Fluids and Solutes
by: Nivedita Agarwal, et al.
Published: (2021-01-01)